Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.23B |
| 2 |
Amazon
AMZN
|
+$792M |
| 3 |
Visa
V
|
+$508M |
| 4 |
AT&T
T
|
+$423M |
| 5 |
Johnson & Johnson
JNJ
|
+$422M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.19B |
| 2 |
Uber
UBER
|
+$1.94B |
| 3 |
CELG
Celgene Corp
CELG
|
+$740M |
| 4 |
Alibaba
BABA
|
+$652M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$561M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.44% |
| 2 | Financials | 10.8% |
| 3 | Healthcare | 10.08% |
| 4 | Consumer Discretionary | 7.71% |
| 5 | Communication Services | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
BioCryst Pharmaceuticals
BCRX
$2.29B
| $3.88M | ﹤0.01% |
1,123,279
+80,648
| +8% | +$203K |
|
|
NOAH
3127
Noah Holdings
NOAH
$577M
| $3.87M | ﹤0.01% |
109,529
-22,096
| -17% | -$674K |
|
3128
Acco Brands
ACCO
$403M
| $3.87M | ﹤0.01% |
413,726
+194,116
| +88% | +$1.84M |
|
|
HNGR
3129
DELISTED
Hanger Inc.
HNGR
| $3.87M | ﹤0.01% |
140,017
+14,976
| +12% | +$355K |
|
|
NEOS
3130
DELISTED
Neos Therapeutics, Inc
NEOS
| $3.87M | ﹤0.01% |
2,559,374
+135,859
| +6% | +$204K |
|
|
REVG
3131
DELISTED
REV Group
REVG
| $3.86M | ﹤0.01% |
315,699
+257,658
| +444% | +$3.26M |
|
3132
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$310M
| $3.86M | ﹤0.01% |
145,460
+58,118
| +67% | +$1.48M |
|
3133
Altisource Portfolio Solutions
ASPS
$60M
| $3.84M | ﹤0.01% |
24,809
-2,089
| -8% | -$320K |
|
|
CLVS
3134
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.82M | ﹤0.01% |
366,802
-146,376
| -29% | -$1.06M |
|
3135
Marcus & Millichap
MMI
$1.17B
| $3.82M | ﹤0.01% |
102,614
+58,996
| +135% | +$2.12M |
|
3136
Sportsman's Warehouse
SPWH
$44.9M
| $3.82M | ﹤0.01% |
475,931
+105,816
| +29% | +$748K |
|
3137
Century Communities
CCS
$2B
| $3.82M | ﹤0.01% |
139,637
+23,194
| +20% | +$679K |
|
|
AXNX
3138
DELISTED
Axonics, Inc. Common Stock
AXNX
| $3.82M | ﹤0.01% |
137,810
+118,966
| +631% | +$2.84M |
|
|
ALLK
3139
CALL
DELISTED
Allakos
ALLK
| $3.81M | ﹤0.01% |
+40,000
| New | +$3.52M |
|
3140
Virtus Biotech Clinical Trials ETF
BBC
$48.5M
| $3.81M | ﹤0.01% |
100,000
| – | – |
|
3141
Chunghwa Telecom
CHT
$32.5B
| $3.81M | ﹤0.01% |
103,123
-13,959
| -12% | -$515K |
|
|
CORE
3142
DELISTED
Core Mark Holding Co., Inc.
CORE
| $3.8M | ﹤0.01% |
139,792
-180,726
| -56% | -$5M |
|
3143
Primoris Services
PRIM
$4.93B
| $3.79M | ﹤0.01% |
170,506
+101,830
| +148% | +$2.18M |
|
3144
James River Group Holdings
JRVR
$213M
| $3.78M | ﹤0.01% |
91,726
-1,032,308
| -92% | -$40.6M |
|
3145
CALL
Check Point Software Technologies
CHKP
$12.7B
| $3.77M | ﹤0.01% |
34,000
+31,000
| +1,033% | +$3.48M |
|
3146
Invesco S&P 500 High Beta ETF
SPHB
$1.03B
| $3.77M | ﹤0.01% |
80,741
+58,715
| +267% | +$2.55M |
|
|
SFIX
3147
Stitch Fix
SFIX
$567M
| $3.76M | ﹤0.01% |
146,557
-268,597
| -65% | -$6.24M |
|
3148
FirstService
FSV
$6.21B
| $3.76M | ﹤0.01% |
40,412
-4,249
| -10% | -$400K |
|
|
3149
CALL
Uber
UBER
$147B
| $3.74M | ﹤0.01% |
125,800
-261,500
| -68% | -$7.76M |
|
3150
PUT
Genworth Financial
GNW
$3.76B
| $3.74M | ﹤0.01% |
850,100
| – | – |
|
Similar funds
Goldman Sachs's Q4 2019 Portfolio in Review
As of Q4 2019, Goldman Sachs held 5,596 positions worth $393B, up 13% from $346B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs deployed $16.2B of net new capital in Q4 2019, opening 456 new positions and adding to 2,467 existing holdings. Its largest new stake was Sprout Social: 10,378,809 shares worth $167M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.19B trimmed.
- Goldman Sachs's largest Q4 2019 buy was Sprout Social: 10,378,809 shares worth $167M.
- Goldman Sachs added most to Microsoft in Q4 2019, an estimated $1.23B increase.
- Goldman Sachs's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.19B.
- Goldman Sachs fully exited Celgene Corp in Q4 2019, selling an estimated $740M.
- Goldman Sachs's ten largest holdings make up 15% of its $393B portfolio in Q4 2019.
- Goldman Sachs opened 456 new positions and closed 410 in Q4 2019.
- Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $393B.
Based on Goldman Sachs's 13F filing for Q4 2019, filed 14 Feb 2020.